Within the last few years, the Federal Circuit and Supreme Court have handed down decisions that altered the landscape of both patent prosecution and enforcement, ranging from venue and attorneys’ fees to the standards for obviousness and patent eligibility. Warren Woessner, a founding shareholder and an expert witness on patent law, will take a look back at the most important IP decisions of 2017-2018 and evaluate their effect on practice in the life sciences arena.